Supernus Pharmaceuticals(SUPN) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Supernus Announces First Quarter 2024 Financial Results ROCKVILLE, MD, May 8, 2024 – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced financial results for the first quarter of 2024 and associated Company developments. "We are pleased to announce another strong quarter for Qelbree, which delivered robust growth of 75% in net sales compared to t ...